HLS Therapeutics
Company Information
HLS Therapeutics is an Etobicoke, Ontario pharmaceutical company focused on acquiring and commercializing late-stage and commercial-stage branded medicines across North America. Public company materials highlight a portfolio aimed at psychiatric disorders and cardiovascular disease, including products such as CLOZARIL and VASCEPA. The company works with originators and manufacturing partners to bring specialty medicines to market.
Industry Focus and Technologies
Pharmaceutical commercialization, specialty branded medicines, cardiovascular therapeutics, psychiatric therapeutics, and North American market access.
Location
Etobicoke, Ontario, Canada
Company Size and Stage
Products, Platforms or Focus Areas
Commercial-stage branded pharmaceutical products focused on central nervous system and cardiovascular conditions, including CLOZARIL and VASCEPA.